From GlobeNewswire: 2025-02-18 10:05:00

The global contraceptives market was valued at USD 26.29 billion in 2023, projected to reach USD 44.71 billion by 2032 with a CAGR of 6.10%. Factors driving growth include increasing family planning awareness, government support, and technological advancements in contraceptives. Rising demand for convenient and cost-effective solutions is fueling market expansion, with a focus on non-hormonal and male contraceptive options.

Key players in the market include AbbVie, Bayer AG, Johnson & Johnson, Pfizer Inc., and Church & Dwight Co., among others. The market scope covers North America, Europe, Asia Pacific, Middle East & Africa, Latin America, with major growth drivers being awareness, accessibility, and government support. Contraceptive devices dominate the market, with long-acting & reversible options like IUDs and implants leading the way.

North America leads the contraceptives market, driven by awareness, healthcare infrastructure, and government initiatives. The Asia-Pacific region is expected to experience the fastest growth due to increasing healthcare investments, rising awareness, and proactive government policies. Recent developments include the Biden administration’s proposal to expand coverage for over-the-counter contraceptives under the Affordable Care Act, potentially taking effect in 2025. SNS Insider, a top market research and consulting agency, offers comprehensive analysis and outlook on the Contraceptives Market from 2024-2032. Access the complete report details at https://www.snsinsider.com/reports/contraceptives-market-2791 for valuable insights and data to make informed decisions in a dynamic market environment. With a focus on providing up-to-date market data, consumer insights, and opinions through various research techniques, SNS Insider equips clients to navigate changing circumstances confidently.



Read more at GlobeNewswire: Contraceptives Market Size to Hit USD 44.71 Billion by